Magnusson, M. K., Dahlén, R., Strid, H., Isaksson, S., Simrén, M., Lasson, A., . . . Öhman, L. (2013). CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis. SAGE Publications.
Παραπομπή Chicago StyleMagnusson, Maria K., Rahil Dahlén, Hans Strid, Stefan Isaksson, Magnus Simrén, Anders Lasson, Antal Bajor, Kjell-Arne Ung, και Lena Öhman. CD25 and TNF Receptor II Reflect Early Primary Response to Infliximab Therapy in Patients With Ulcerative Colitis. SAGE Publications, 2013.
Παραπομπή MLAMagnusson, Maria K., et al. CD25 and TNF Receptor II Reflect Early Primary Response to Infliximab Therapy in Patients With Ulcerative Colitis. SAGE Publications, 2013.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.